[go: up one dir, main page]

Brott et al., 1991 - Google Patents

Overview of hemostasis and thrombosis

Brott et al., 1991

Document ID
12080903542838551590
Author
Brott T
Stump D
Publication year
Publication venue
Seminars in Neurology

External Links

Snippet

In the absence of'vasculal-injury, blood flow proceeds without any ongoing activation of'platelets and without activation of'the coagulation cascade.'Following vascular in-jury, the complex process of thrombosis is triggered. Tissue factors are exposed or released that …
Continue reading at www.thieme-connect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Falanga et al. Pathogenesis of thrombosis in patients with malignancy
Levi Inflammation and coagulation
Lawson et al. Challenges for providing effective hemostasis in surgery and trauma
Smith et al. How it all starts: Initiation of the clotting cascade
Esmon Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis
Hedner Mechanism of action, development and clinical experience of recombinant FVIIa
Garabedian et al. Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis
Ohlstein et al. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit
Rodgers et al. Characterization of the effects of cultured vascular cells on the activation of blood coagulation
Niewiarowski et al. Activation of intravascular coagulation by collagen.
Pitney et al. Blood fibrinolytic activity during Arvin therapy
Schulman Studies on the medical treatment of deep vein thrombosis
Arnljots et al. Prevention of experimental arterial thrombosis by topical administration of active site–inactivated factor VIIa
Dubber et al. In vitro and in vivo studies with Trasylol, an anticoagulant and a fibrinolytic inhibitor
Olson Mechanisms of hemostasis: effect on intracerebral hemorrhage
Fruchtman et al. Disseminated intravascular coagulation
Brott et al. Overview of hemostasis and thrombosis
Taylor et al. Role of the inflammatory response in the hemorrhagic syndrome induced by the hemolymph of the caterpillar Lonomia achelous
Sniecinski et al. Reduced levels of fibrin (antithrombin I) and antithrombin III underlie coagulopathy following complex cardiac surgery
Fareed et al. Modulation of smooth muscle responses by serine proteases and related enzymes
Jeljaszewicz et al. Intravascular Coagulation and Fibrinolysis by Stapliylocoagiilase. Comparison with Thrombin
Locht et al. Severe skin necrosis following warfarin therapy in a patient with protein C deficiency
Gurewich Guidelines for the management of anticoagulant therapy
Stern et al. Endothelium and the regulation of coagulation
WO1991002532A2 (en) Method for stimulating fibrinolytic effect